Search

everythinglearnresearchcommunity

for

Search:↓

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Finasteride increases CD8+ T cells in BPH tissues.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Dutasteride improved both hair loss and acne in two young men.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Finasteride and dutasteride reduce semen quality, with dutasteride having a stronger negative effect.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Finasteride improves hair loss in women with hyperandrogenism.

Aδ-LTMRs have complex synapses with glycine, while Aβ-LTMRs have simpler ones.

Finasteride may improve stem cell therapy for heart attacks by increasing cell survival.

Male pattern baldness is mainly caused by genetics and hormones, treatable with minoxidil and finasteride.